INNOVADERM CRO IS NOW INDERO.

Senior Clinical Research Associate, Dermatology & Rheumatology, USA

USA · Permanent · Professional

About The Position

Senior Clinical Research Associate, Dermatology & Rheumatology (North Central Regions: Illinois, Indiana, Michigan, Ohio, and/or Wisconsin or East coast )


The senior clinical research associate (CRA) will monitor the progress of clinical studies at investigative sites or remotely, and ensure clinical trials are conducted, recorded, and reported in accordance with the protocol, standard operating procedures (SOPs), ICH-GCP, and all applicable regulatory requirements.


This role will be perfect for you if:

  • You are a seasoned Clinical Research Associate (CRA) who thrives in autonomous environments and consistently meets high-quality standards and deadlines.
  • You bring experience in dermatology and rheumatology, and you're eager to deepen your expertise in these therapeutic areas.
  • You value working within a mid-sized CRO where your contributions are visible, appreciated, and have a direct impact.


RESPONSIBILITIES 

The senior clinical research associate (CRA):

  • Conducts site qualification, initiation, monitoring, and close-out visits for research sites according to the monitoring plan, Innovaderm and sponsor SOPs, ICH/CGP guidelines and applicable regulations
  • Participates in investigators’ meetings
  • Prepares site visit reports and follow-up letters to the investigator
  • Builds productive relationships with investigators and site staff to achieve study objectives, including patient recruitment targets
  • Performs source data verification, ensures on-site study drug storage, dispensing, and accountability, data collection, and regulatory document collection is adequate


The Sr CRA may also assume the following Lead CRA responsibilities: 

  • Reviews and approves site visit reports. 
  • Tracks site visit and trip report metrics and escalates issues to project teams. 
  • Recommends potential solutions to identified issues and work with the project managers to find resolution. 
  • Supports the development of annotated site visit reports, clinical monitoring plans, and monitoring tools. 
  • Supports the preparation and development of materials related to the training of CRAs. 
  • Mentors CRAs.  
  • Conducts on-site quality control visits with CRAs. 


Requirements

Education

  • B.Sc. in a field relevant to clinical research, nursing degree and/or equivalent experience

Experience

  • At least 5 years experience in conducting on-site clinical monitoring in the biotechnology, pharmaceutical, and/or contract research organization (CRO) industry
  • Rheumatology exposure

Knowledge and skills

  • Good knowledge of ICH/GCP standards and applicable regulatory requirements
  • Strong verbal and written communication skills in English
  • Ability to prioritize different assignments and work under pressure while maintaining attention to detail and meeting timelines
  • Excellent judgement and problem-solving skills
  • Travel to research sites approximately 65% of the time
  • Excellent knowledge of Microsoft Office (i.e., Word, Excel, PowerPoint)
  • Experience in dermatology is an asset

Our company

The work environment

 

At Indero, you will work with brilliant and driven colleagues. Our values are collaboration, innovation, reliability and responsiveness. We offer a stimulating work environment and attractive advancement opportunities. 

 

Recruitment process: what to expect

  • As part of the recruitment process for this position you will meet various team members at Indero
  • The first interview will be conducted by Teams (30 minutes) and the second via video conference (1 hour)


About Indero  


A Global Clinical Leader In Dermatology and Rheumatology!


Formerly known as Innovaderm, Indero is a world-renowned expert and clinical research leader in dermatology. We have more than two decades of experience serving a broad range of indications, patient populations, administration routes, and drug classes, and a global footprint.


Indero is a dual-focus CRO for dermatology and rheumatology, with 25+ years’ experience in clinical research and trial delivery. Our full-service approach – which includes everything from protocol design and patient recruitment to trial monitoring and biometrics – provides biotech and pharmaceutical sponsors with the rigorous scientific foundation and tailored expertise their studies need to reach the finish line efficiently and effectively. With capabilities in North America, Europe, Asia Pacific and Latin America; vast, continuously growing relationships with investigators and patients; and a dedicated research clinic through which we design and execute our own studies, Indero is the ideal CRO partner for clinical needs at global scale.

 

Indero is committed to providing equitable treatment and equal opportunity to all individuals. As such, Indero will provide accommodations throughout the recruitment and selection process to applicants with disabilities, upon request. 


Indero only accepts applicants who can legally work in United States.

Apply for this position

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.